STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $87,240 | 0.0% | 10,473 | 0.0% | 0.00% | – |
| Q1 2023 | $87,240 | -9.8% | 10,473 | 0.0% | 0.00% | – |
| Q4 2022 | $96,666 | -46.3% | 10,473 | -25.2% | 0.00% | – |
| Q3 2022 | $180,000 | -2.7% | 14,003 | 0.0% | 0.00% | – |
| Q2 2022 | $185,000 | -16.7% | 14,003 | +112.4% | 0.00% | – |
| Q2 2021 | $222,000 | -21.8% | 6,593 | +44.0% | 0.00% | -100.0% |
| Q4 2020 | $284,000 | – | 4,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
| RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
| Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
| RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
| Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
| GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
| Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
| Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
| Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |